InstaTrac, Inc. – Trademark Portfolio
Entity Type: 03
InstaTrac, Inc. owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as MASSTRAC, MUNITRAC, and MASSINSIDER. Of these, 3 are registered. The portfolio spans 4 Nice Classification classes, led by Class 45 (Legal & Security Services) and Class 35 (Advertising & Business). Headquartered in Boston, MA.
45 Bromfield St., Ste. 1101
Boston, MA 02108
Showing of trademarks Trademarks
Trademark Classifications
InstaTrac, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Legal services; security services for the protection of property and individuals
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does InstaTrac, Inc. have?
InstaTrac, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.
What trademark classes does InstaTrac, Inc. file in?
InstaTrac, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 45 (Legal & Security Services), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 45 covers legal services; security services for the protection of property and individuals.
What are InstaTrac, Inc.'s most well-known trademarks?
InstaTrac, Inc.'s registered trademark portfolio includes well-known marks such as MASSTRAC, MUNITRAC, and MASSINSIDER. These are among 3 currently registered trademarks in the portfolio.
What is InstaTrac, Inc.'s trademark registration success rate?
InstaTrac, Inc. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.